Phytol, a branched-chain fatty alcohol, is the naturally occurring precursor of phytanic and pristanic acid, branched-chain fatty acids that are both ligands for the nuclear hormone receptor peroxisome proliferator-activated receptor a (PPARa). To investigate the metabolism of phytol and the role of PPARa in its regulation, wild-type and PPARa knockout (PPARa 2/2 ) mice were fed a phytolenriched diet or, for comparison, a diet enriched with Wy-14,643, a synthetic PPARa agonist. After the phytolenriched diet, phytol could only be detected in small intestine, the site of uptake, and liver. Upon longer duration of the diet, the level of the (E)-isomer of phytol increased significantly in the liver of PPARa 2/2 mice compared with wildtype mice. Activity measurements of the enzymes involved in phytol metabolism showed that treatment with a PPARa agonist resulted in a PPARa-dependent induction of at least two steps of the phytol degradation pathway in liver. Furthermore, the enzymes involved showed a higher activity toward the (E)-isomer than the (Z)-isomer of their respective substrates, indicating a stereospecificity toward the metabolism of (E)-phytol. In conclusion, the results described here show that the conversion of phytol to phytanic acid is regulated via PPARa and is specific for the breakdown of (E) Phytol is a branched-chain fatty alcohol (3,7,11,15-tetramethylhexadec-2-en-1-ol) that is abundantly present in nature as part of the chlorophyll molecule. The release of phytol from chlorophyll occurs effectively in the digestive system of ruminant animals only, presumably by bacteria present in the gut (1). As a result, a relatively high amount of free phytol is present in dairy products (2). In mammals, free phytol is readily absorbed in the small intestine and is metabolized to phytanic acid, a fatty acid that accumulates in a number of metabolic disorders. Increased levels of phytanic acid in the body are toxic, so this fatty acid needs to be broken down (3-9). Because the methyl-group at the 3 position prevents b-oxidation, phytanic acid first has to undergo a round of a-oxidation. This results in the formation of pristanic acid, which is one carbon atom shorter than phytanic acid and can be normally b-oxidized (10). A deficiency in a-oxidation, such as in Refsum disease, leads to increased levels of phytanic acid in plasma and tissues of patients, and this is thought to cause the main clinical symptoms of this disorder: retinitis pigmentosa, peripheral neuropathy, and cerebellar ataxia (3, 4). Because the breakdown of phytol will contribute to the phytanic and pristanic acid levels in these patients, it is important to study its metabolism and regulation.In many animal studies, phytol is used as a precursor of phytanic acid. Addition of phytol to the diet results in an increase of phytol metabolites in tissues and plasma (6,(11)(12)(13). This has been used as a model to study the effects of the accumulation of phytol metabolites on fatty acid metabolism, in particular via the activation of the nu...